Bioscience

Organizations seek tax-deductible year-end gifts to fund innovation

Organizations seek tax-deductible year-end gifts to fund innovation

FORT COLLINS/DENVER - The Rocky Mountain Innosphere in Fort Collins and the Colorado BioScience Association in Denver are looking for year-end gifts to help fund their efforts to support... Read More

By: Steve Thursday December 20, 2012 0 comments Tags: April Giles, BioGENEius Challenge, Denver, Doug Johnson, Fort Collins, Fund for Innovation, PhRMA, RMI

Sharklet Technologies closes $2M in Series B financing from Altria Ventures

Sharklet Technologies closes $2M in Series B financing from Altria Ventures

AURORA - Sharklet Technologies has attracted capital from Altria Ventures for accelerating the growth and development of Sharklet, the world's first bacteria-inhibiting, micro-texture surface... Read More

By: Steve Tuesday December 18, 2012 0 comments Tags: Altria Group, Altria Ventures, Aurora, Joe Bagan

CHD Bioscience, CSU to jointly explore infectious disease treatment through R&D agreement

CHD Bioscience, CSU to jointly explore infectious disease treatment through R&D agreement

FORT COLLINS - CHD Bioscience Inc. has signed a master research and development agreement with Colorado State University, the company announced. The agreement outlines the working... Read More

By: Steve Tuesday December 18, 2012 0 comments Tags: Bill Farland, CHD Bioscience, CSU, Ed Neas, Fort Collins, infectious disease, Mike Handley

Ventria's Optiferrin shown functionally comparable to human transferrin in published study

Ventria's Optiferrin shown functionally comparable to human transferrin in published study

FORT COLLINS - Ventria Bioscience's Optiferrin recombinant human transferrin has been shown functionally comparable to purified human transferrin in a study just published by the journal BMC... Read More

By: Steve Friday December 14, 2012 0 comments Tags: Dr. Ning Huang, Dr. Wei-Chiang Shen, ExpressTec, Fort Collins, InVitria, Optiferrin, Ventria Bioscience

AspenBio Pharma changes its name to Venaxis

AspenBio Pharma changes its name to Venaxis

CASTLE ROCK - Venaxis Inc. (Nasdaq: APPY) - formerly AspenBio Pharma - has changed its corporate name after a recent meeting of its shareholders, the company announced. The company's... Read More

By: Steve Friday December 14, 2012 0 comments Tags: AspenBio Pharma, Castle Rock, Steve Lundy, Venaxis

Colibri announces successful clinical use of first ready-to-use transcatheter heart valve

Colibri announces successful clinical use of first ready-to-use transcatheter heart valve

BROOMFIELD - Colibri Heart Valve LLC has successfully completed the first clinical use of its proprietary transcatheter aortic heart valve, the company announced. The transcatheter aortic... Read More

By: Steve Thursday December 13, 2012 0 comments Tags: Broomfield, Colibri, Colibri Heart Valve, Joseph B. Horn, TAVI

Cerapedics secures $19M in equity financing to advance bone graft R&D

Cerapedics secures $19M in equity financing to advance bone graft R&D

WESTMINSTER - Cerapedics Inc. today announced it has completed a Series C round of private equity financing totaling $19 million. The new round was led by new investors Medimmune Ventures... Read More

By: Steve Wednesday December 12, 2012 0 comments Tags: Cerapedics, CVF LLC, i-FACTOR, Medimmune Ventures, NGN Capital, OrbiMed Advisors, osteobiologics, Paul Mraz, Sam Wu, Westminster

CU-led team will use $9.2M DOE grant to modify E.coli bacteria into biofuels

CU-led team will use $9.2M DOE grant to modify E.coli bacteria into biofuels

BOULDER - A team led by the University of Colorado Boulder has been awarded $9.2 million over the next five years from the U.S. Department of Energy to research modifying E.coli to... Read More

By: Steve Tuesday December 11, 2012 0 comments Tags: Adam Arkin, biofuels, Boulder, DOE, E-coli, NREL, Pin-Ching Maness, Rob Knight, Ryan Gill